EUVIMEDEUVIMED entdecken
Vergleichsstudie

Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF

Mahmoud Eisa iD, Hossam Elbenawi, Momina Iftikhar, Ahmed El Shaer, Muhammad Eltony iD, Omar Almaadawy, Amro Aglan, Mahmoud Samy Ahmed, Kareem A Mohamed, Khaled Elfert, Mahmoud Shadi, Mohan Rao und 7 weitere

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70166 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Mahmoud Eisa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: The authors received no specific funding for this work. All analyses were conducted independently using the TriNetX platform..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early catheter ablation for atrial fibrillation (AF) improves outcomes, but the optimal timing, especially in heart failure (HF) subtypes, remains unclear.

Objective

To evaluate the impact of ablation timing on outcomes in patients with HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).

Methods

We used the TriNetX database (2010–2024) to identify HF patients with AF who underwent ablation. Patients were classified as early ablation (≤ 1 year of first AF diagnosis) or delayed ablation (1–3 years), with propensity score matching (PSM) applied to balance the baseline characteristics. The primary outcome was AF recurrence, defined by repeat ablation, direct current cardioversion (DCCV), or antiarrhythmic drug (AAD) use after a 3‐month blanking period. Secondary outcomes included stroke, hospitalization, and mortality over 5 years.

Results

After PSM, delayed ablation was associated with higher AF recurrence in both HFrEF (HR = 1.28, p < 0.001) and HFpEF (HR = 1.21, p = 0.02), as seen in multivariate analysis. In HFrEF, delayed ablation was associated with higher incidence of re‐do ablation, AAD use, and DCCV, while in HFpEF, higher recurrence with delayed ablation was associated with increased AAD use. Both cohorts had similar stroke and mortality rates between early and delayed ablation.

Conclusions

Delayed ablation in HFrEF and HFpEF was linked to higher AF recurrence, driven by increased redo ablations, DCCV, AAD use in HFrEF, and higher AAD use in HFpEF. Stroke, HF hospitalization and mortality rates were similar, suggesting earlier ablation may enhance rhythm control over other outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationHeart FailureStroke VolumeTime-to-TreatmentVentricular Function, LeftHumansMaleFemaleRecurrenceAgedTreatment OutcomeMiddle AgedTime FactorsRisk FactorsDatabases, FactualRisk AssessmentRetrospective StudiesHeart RateAction Potentials

Stichwörter der Autor:innen

atrial fibrillationcatheter ablationheart failure with preserved ejection fraction (HFpEF)heart failure with reduced ejection fraction (HFrEF)

Autor:innen und Institutionen

  • Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Internal Medicine, NewYork-Presbyterian Queens, Queens, New York, USA.
  • Department of Internal Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Department of Internal Medicine, MedStar Health, Baltimore, Maryland, USA.
  • Department of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, New York, USA.

ORCID-Profile: Mahmoud Eisa, Muhammad Eltony, Freddy Del-Carpio Munoz, Konstantinos C Siontis, Mark S Link, Abhishek J Deshmukh, Christopher V DeSimone

Förderung

  • The authors received no specific funding for this work. All analyses were conducted independently using the TriNetX platform.

Zitieren

APA

Eisa, M., Elbenawi, H., Iftikhar, M., El Shaer, A., Eltony, M., Almaadawy, O., Aglan, A., Ahmed, M. S., Mohamed, K. A., Elfert, K., Shadi, M., Rao, M., Lee, J. Z., Asad, Z. U. A., Munoz, F. D., Siontis, K. C., Link, M. S., Deshmukh, A. J., & DeSimone, C. V. (2026). Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70166

Vancouver

Eisa M, Elbenawi H, Iftikhar M, El Shaer A, Eltony M, Almaadawy O, et al. Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70166

BibTeX
@article{Eisa2026,
  author = {Eisa, Mahmoud and Elbenawi, Hossam and Iftikhar, Momina and El Shaer, Ahmed and Eltony, Muhammad and Almaadawy, Omar and Aglan, Amro and Ahmed, Mahmoud Samy and Mohamed, Kareem A and Elfert, Khaled and Shadi, Mahmoud and Rao, Mohan and Lee, Justin Z and Asad, Zain Ul Abideen and Munoz, Freddy Del-Carpio and Siontis, Konstantinos C and Link, Mark S and Deshmukh, Abhishek J and DeSimone, Christopher V},
  title = {Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70166}
}
Kostenlos starten →